Kynurenate is neuroprotective following experimental brain injury in the rat

Brain Research

Volumn 655, Issue 1-2, 1994, Pages 91-96

  Hicks, Ramona R ^a   Smith, Douglas H ^b   Gennarelli, Thomas A ^b   McIntosh, Tracy ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Excitotoxicity; Head injury pathology; Hippocampus; Kynurenate; Neuroprotection; NMDA antagonist

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; KYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BODY TEMPERATURE; BRAIN INJURIES; CELL SURVIVAL; HIPPOCAMPUS; KYNURENIC ACID; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028105981     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(94)91601-2     Document Type: Article

References (52)

1. Progress review: hypoglycemic brain damage
2. An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo
3. Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient ischemia monitored by intracerebral microdialysis
4. Kynurenic acid inhibits the activation of kainic and N-methyl-d-aspartic acid-sensitive ionotropic receptors by a different mechanism
5. Kynurenate and FG9041 have both competitive and noncompetitive antagonist actions at excitatory amino acid receptors
6. Hypothermia but not the N-methyl-d-aspartate, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia
7. Glutamate toxicity and diseases of the nervous system
8. Glutamate neurotoxicity in cortical cell culture
9. MK801 reduced cerebral ischemic injury by inducing hypothermia
10. Vascular disruption and neuronal and glial alterations
11. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
12. Kynurenate inhibition of excitation decreases stroke size and deficits
13. Effect of ischemia on the in vivo release of striatal dopamine, glutamate and gamma-aminobutyric acid studied by intracerebral microdialysis
14. Neurotransmitter mediated mechanisms of traumatic brain injury: Acetylcholine and excitatory amino acids
15. Pretreatment with phenycyclidine, an N-methyl-d-aspartate receptor antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury
16. Indole-2-carboxylic acid: a competitive antagonist of potentiation by glycine at the NMDA receptor
17. Temporo-spatial mapping of neuronal degeneration after lateral fluid-percussion brain injury in the rat
18. Combined pre-trauma scopolamine and phencyclidine attenuates pos-traumatic increased sensitivity to delayed secondary ischemia
19. Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury
20. Neurochemistry and neurophysiology of phencyclidine
21. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose
22. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury
23. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-d-aspartate receptor complex
24. The glycine site of the NMDA receptor — five years on
25. Delayed neuronal death in the gerbil hippocampus following ischemia
26. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes
27. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head traum and disorders of the hippocampus
28. Role of excitatory amino acid neurotransmitters in the pathogenesis of traumatic brain injury
29. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model
30. Effect of noncompetitive blockade of N-methyl-d-aspartate receptors on the neurochemical sequelae of experimental brain injury
31. Effects of the N-methyl-d-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury
32. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
33. Identification and properties of N-methyl-d-aspartate receptors in rat brain plasma membranes
34. Learning and memory
35. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina
36. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats
37. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs
38. The role of specific ions in glutamate neurotoxicity
39. Role of Ca [2+] in toxic killing
40. Temporal profile of neuronal damage in a model of transient forebrain ischemia
41. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
42. Verbal memory impairment correlates with hippocampal pyramidal cell density
43. Selective vulnerability of the hippocampus in brain ischemia
44. Historical Overview.
45. Protective effect of MK801 in experimental brain injury
46. Excitotoxic mechanisms in hypoglycaemic hippocampal injury
47. Evaluation of memory dysfunction following experimental brain injury using the Morris water maze
48. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid, on behavioral and neurochemical outcome following experimental brain injury
49. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans
50. Computational constraints suggest the need for two distinct input systems to the hippocampal CA3 network
51. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil
52. Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury